The EVERY Co has urged a court in Wisconsin to toss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...

The University of Liverpool rand CyanoCapture Ltd are joining forces to develop the next generation of carboxysome-based ...

Vishal Mukund Sonje, Vaccine Manufacturing Lead, CEPI, talks about the challenges that arise in the manufacturing of vaccines ...

The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted ...

Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), ...

Researchers immunized an alpaca and a llama with snake venoms, and combined some of the antibodies produced into a potent ...

If approved, the drug could become the first treatment for haemorrhagic stroke outside of surgical intervention.

From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international ...

Net Loss -- Net loss was $13.6 million for the third quarter of 2025, compared to $16.4 million in Q3 2024. Ending Cash, Cash ...

Immunologist Zachary Rubin explains how the World Health Organization decides which strains of influenza end up in annual flu ...

The medical use of horseshoe crabs highlights the dilemma between human safety, environmental sustainability, and scientific ...